Pharma cos to lose pandemic-induced pricing power in Q2 as economies reopen: Report

The pharma companies cumulatively saw their pre-tax margins rising by
306 basis points (bps) on an annualised basis and 551 bps sequentially
in the first quarter.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pharma-cos-to-lose-pandemic-induced-pricing-power-in-q2-as-economies-reopen-report/articleshow/77719059.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation